Professor Olivier Michielin Discusses mRNA Advances in Le Temps
Patients, Clinicians, Scientists
The Translational Research Centre in Onco-Hematology (CRTOH), coordinated by Professors Mikael Pittet and Olivier Michielin, is dedicated to promoting translational and interdisciplinary cancer research that has the potential to quickly benefit patients. This involves a close collaboration between clinicians and researchers, and a proximity with the patients. The Centre also aims to promote the training of the next generation of researchers and clinicians focusing on translational cancer research.
The CRTOH comprises 34 research groups and more than 300 collaborators. Our ongoing research efforts are centered around several key areas, including tumor immunology and immunotherapy, precision oncology, cell division and cancer, and cancer pharmacology.
Latest News
Patrycja Nowak-Sliwinska was awarded the prestigious European Certified Pharmacologist (EuCP) designation
Denis Migliorini has been promoted to Associate Professor
Efficacy of Immune Checkpoint Inhibitors and Oncoviruses in Solid Tumors
Revolutionising oncology through precision medicine
Camilla Jandus: "Our immune defences are still far from having revealed all their secrets"